Lipid droplet biogenesis and functions in health and disease
Ubiquitous yet unique, lipid droplets are intracellular organelles that are increasingly being
recognized for their versatility beyond energy storage. Advances uncovering the intricacies …
recognized for their versatility beyond energy storage. Advances uncovering the intricacies …
New perspectives in diabetic neuropathy
Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D),
which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy …
which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy …
[HTML][HTML] Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of …
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko… - The Lancet, 2023 - thelancet.com
Background Diabetes is one of the leading causes of death and disability worldwide, and
affects people regardless of country, age group, or sex. Using the most recent evidentiary …
affects people regardless of country, age group, or sex. Using the most recent evidentiary …
Regulation of biological processes by intrinsically chiral engineered materials
Chirality has a key role in the synthesis of biomolecules and the development of life.
Although the effects of many chiral molecules or materials on biological processes have …
Although the effects of many chiral molecules or materials on biological processes have …
Artificial intelligence in ophthalmology: The path to the real-world clinic
Z Li, L Wang, X Wu, J Jiang, W Qiang, H Xie… - Cell Reports …, 2023 - cell.com
Artificial intelligence (AI) has great potential to transform healthcare by enhancing the
workflow and productivity of clinicians, enabling existing staff to serve more patients …
workflow and productivity of clinicians, enabling existing staff to serve more patients …
Dissecting causal associations of type 2 diabetes with 111 types of ocular conditions: a Mendelian randomization study
R Chen, S Xu, Y Ding, L Li, C Huang, M Bao… - Frontiers in …, 2023 - frontiersin.org
Background Despite the well-established findings of a higher incidence of retina-related eye
diseases in patients with diabetes, there is less investigation into the causal relationship …
diseases in patients with diabetes, there is less investigation into the causal relationship …
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
M Kosmalski, A Śliwińska, J Drzewoski - Biomedicines, 2023 - mdpi.com
In clinical practice, we often deal with patients who suffer from non-alcoholic fatty liver
disease (NAFLD) concurrent with type 2 diabetes mellitus (T2DM). The etiopathogenesis of …
disease (NAFLD) concurrent with type 2 diabetes mellitus (T2DM). The etiopathogenesis of …
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial
Summary Background In sub-Saharan Africa, health-care provision for chronic conditions is
fragmented. The aim of this study was to determine whether integrated management of HIV …
fragmented. The aim of this study was to determine whether integrated management of HIV …
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Oral administration is the preferred route of administration based on the convenience for and
compliance of the patient. Oral nanomedicines have been developed to overcome the …
compliance of the patient. Oral nanomedicines have been developed to overcome the …
[PDF][PDF] Efficacy and safety of mazdutide in chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 2 trial
B Zhang, Z Cheng, J Chen, X Zhang, D Liu… - Diabetes …, 2024 - Am Diabetes Assoc
OBJECTIVE We conducted a randomized, double-blind, placebo-controlled phase 2 trial to
evaluate the efficacy and safety of mazdutide, a once-weekly glucagon-like peptide 1 and …
evaluate the efficacy and safety of mazdutide, a once-weekly glucagon-like peptide 1 and …